Trial Outcomes & Findings for RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial (NCT NCT00364689)

NCT ID: NCT00364689

Last Updated: 2019-09-17

Results Overview

Recruitment status

TERMINATED

Study phase

PHASE3

Target enrollment

13 participants

Primary outcome timeframe

Month 7

Results posted on

2019-09-17

Participant Flow

The number of participants that were assigned to each Arm/Group is not known due to the data for this study no longer being available as the retention period has passed.

Participant milestones

Participant milestones
Measure
All Participants
Overall Study
STARTED
13
Overall Study
COMPLETED
12
Overall Study
NOT COMPLETED
1

Reasons for withdrawal

Reasons for withdrawal
Measure
All Participants
Overall Study
Lost to Follow-up
1

Baseline Characteristics

RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: Month 7

Population: Outcome measure data is not reported as the study was terminated due to difficulty with enrolling participants. Collection of data ceased and data analysis was not performed. Data collected is no longer available as the retention period has passed.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: Month 7

Population: Outcome measure data is not reported as the study was terminated due to difficulty with enrolling participants. Collection of data ceased and data analysis was not performed. Data collected is no longer available as the retention period has passed.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Month 7

Population: Outcome measure data is not reported as the study was terminated due to difficulty with enrolling participants. Collection of data ceased and data analysis was not performed. Data collected is no longer available as the retention period has passed.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Month 7

Population: Outcome measure data is not reported as the study was terminated due to difficulty with enrolling participants. Collection of data ceased and data analysis was not performed. Data collected is no longer available as the retention period has passed.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Month 7

Population: Outcome measure data is not reported as the study was terminated due to difficulty with enrolling participants. Collection of data ceased and data analysis was not performed. Data collected is no longer available as the retention period has passed.

Outcome measures

Outcome data not reported

Adverse Events

All Study Participants

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Clinical Trial Disclosure Manager

University of Miami

Phone: 305-243-0494

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place